¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"minimal volition period"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® incubation period, latent stage ÇÑ±Û Àẹ±â, ¹è¾ç±â°£
¼³¸í   
  1. º´¿øÃ¼°¡ Ã¼³»¿¡ Ä§ÀÔ(°¨¿°)ÇÑ ÈÄ ±×·Î ÀÎÇÑ °¨¿°ÁõÀÌ ¹ßº´ÇÒ ¶§±îÁöÀÇ ±â°£. º´¿øÃ¼ÀÇ Á¾·ù¿¡ µû¶ó ±× ³»¿ëÀÌ ´Ù¸£´Ù. ¿¹ÄÁ´ë ¸»¶ó¸®¾Æ´Â Ä§ÀÔÇÑ º´¿øÃ¼°¡ ÀÎü ³»¿¡¼­ ÀÏÁ¤ÇÑ ´Ü°è±îÁö ¹ßÀ°ÇÑ ÈÄ ¹ßº´Çϰí, ÀåÆ¼Çª½º´Â Ä§ÀÔÇÑ º´¿ø±ÕÀÌ ÀÏÁ¤ÇÑ ¼ö±îÁö ¹ø½ÄÀ» Çؾߠ¹ßº´Çϸç, ÆÄ»ódzÀº Ä§ÀÔÇÑ º´¿ø±ÕÀÌ »ý¼ºÇÑ µ¶¼Ò°¡ ³ú½Å°æ¿¡ ´ÞÇÑ ÈÄ¿¡ ¹ßº´ÇÑ´Ù. °°Àº º´À̶󵵠ħÀÔÇÑ º´¿øÃ¼ÀÇ ¾çÀ̳ª µ¶·Â, °¨¿°µÈ »ç¶÷ÀÇ °¨¼ö¼º µî¿¡ µû¶ó¼­µµ ´Þ¶óÁø´Ù. º¸Åë Àẹ±â¿¡´Â º´Àû Â¡Èİ¡ ³ªÅ¸³ªÁö ¾ÊÁö¸¸ ¹Î°¨ÇÑ »ç¶÷ÀÇ °æ¿ì´Â µÎÅë-½Ä¿åºÎÁø-Çö±âÁõ-ºÒÄè°¨°ú °°Àº Àü±¸Áõ»óÀ» ³ªÅ¸³»´Â ¼öµµ ÀÖ´Ù. 2. º¸¿Â±â°£, ¹è¾ç±â°£, ¹ßÀ°¿¡ ÇÊ¿äÇÑ ±â°£. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal volition period
    ÃÖ¼Ò¼öÃà±â
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maximal volition period
    ÃÖ´ë¼öÃà±â
  • volition
    ÀÇÁö, ÀÇ¿å
  • minimal
    ÃÖ¼Ò-
  • minimal alveolar concentration
    ÃÖ¼ÒÆóÆ÷³óµµ
  • minimal anesthetic concentration
    ÃÖ¼Ò¸¶Ãë³óµµ
  • minimal angle resolution
    ÃÖ¼Ò°¢ºÐÇØ´É
  • minimal bactericidal concentration
    ÃÖ¼Ò»ì±Õ³óµµ
  • minimal blocking concentration
    ÃÖ¼ÒÂ÷´Ü³óµµ
  • minimal brain dysfunction
    °æ¹Ì³ú±â´ÉÀå¾Ö
  • minimal change disease
    ¹Ì¼¼º¯È­º´
  • minimal current gradient
    ÃÖ¼ÒÀü·ù±â¿ï±â, ÃÖ¼ÒÀü·ù°æ»ç
  • minimal effective analgesic concentration
    ÃÖ¼ÒÈ¿°úÁøÅë³óµµ
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • minimal erythema dose
    ÃÖ¼ÒÈ«¹Ý¼±·®
  • minimal identifiable odor
    ÃÖ¼ÒÀνij¿»õ, ÃÖ¼ÒºÐÇØÃë°¢
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal invasive surgery
    ÃÖ¼Òħ½À¼ö¼ú
  • period
    ÁÖ±â
  • ejection period
    ¹ÚÃâ±â
  • incubation period
    Àẹ±â
  • induction period
    À¯µµ±â
  • involutional period
    °»³â±â
  • lag period
    Áõ½ÄÁغñ±â, Áö¿¬±â
  • latent period
    ÀáÀç±â , Àẹ±â
  • neonatal period
    ½Å»ý¾Æ±â
  • paroxysmal period
    ¹ßÀÛ±â
  • postmenopausal period
    Æó°æÈıâ
  • premenstrual period
    ¿ù°æÀü±â
  • prenatal period
    ºÐ¸¸Àü±â
  • puerperal period
    »êÈıâ, »ê¿å±â
  • refractory period
    ºÒÀÀ±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal volition period
    ÃÖ¼Ò¼öÃà±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maximal volition period
    ÃÖ´ë¼öÃà±â
  • volition
    ÀÇÁö, ÀÇ¿å
  • minimal visible angle
    Ãּҽð¢
  • minimal alveolar concentration
    ÃÖ¼ÒÆóÆ÷³»³óµµ
  • minimal anesthetic concentration
    ÃÖ¼Ò¸¶Ãë³óµµ
  • minimal bactericidal concentration
    ÃÖ¼Ò»ì±Õ³óµµ
  • minimal blocking concentration
    ÃÖ¼ÒÂ÷´Ü³óµµ
  • minimal effective analgesic concentration
    ÃÖ¼ÒÈ¿°úÁøÅë³óµµ
  • minimal inhibitory concentration
    ÃÖÀú¾ïÁ¦³óµµ, ÃÖÀúÀúÁö³óµµ
  • minimal brain dysfunction
    °æ¹Ì³ú±â´ÉÀå¾Ö, ¹Ì¼Ò³ú±â´ÉÀå¾Ö
  • minimal change disease
    ÃÖ¼Òº¯È­ÄáÆÏº´Áõ
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • minimal erytherma dose
    ÃÖ¼ÒÈ«¹Ý¼±·®
  • minimal lethal dose
    ÃÖ¼ÒÄ¡»ç·®, ÃÖ¼ÒÄ¡»ç¼±·®
  • minimal enhancement
    ¹Ì¹ÌÇÑÁ¶¿µÁõ°­, °æµµÁ¶¿µÁõ°­
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Kobraks minimal stimulation
    ÄÚºê¶ô¾àÀڱعý
  • Oedipal period
    ¿¡µðǪ½º½Ã±â(¡­ãÁÑ¢).
  • absolute refractory period
    Àý´ëºÒÀÀ±â(¡­ÝÕëëÑ¢)
  • alveolar period
    ²Ê¸®½Ã±â
  • generalization period
    ¸¸¿¬±â(ËÎËçË»).
  • generalization period
    ¸¸¿¬±â(ØÀæÅÑ¢).
  • gestation period
    ÀӽűⰣ(¡­Ñ¢Êà).
  • gestational period
    Àӽűâ
  • growth period
    ¼ºÀå±â(à÷íþÑ¢).
  • induction period
    À¯µµ±â(ë¯ÓôÐï).
  • induction period
    À¯µµ±â.
  • initial fetal period
    žÆÃʱâ
  • initial period of limb buds
    ÆÈ´Ù¸®½ÏÃʱâ
  • initial period of neural groove
    ½Å°æ°í¶ûÃʱâ
  • initial period of pharyngeal arch
    ÀεαÁÀÌÃʱâ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • volition
    ÀÇÁö(ëòò¤), ÀÇ¿å(ëòé¯).
  • volition
    ÀÇÁö(ëòò¤), ÀÇ¿å(ëòé¯)
  • minimal air
    ÃÖ¼Ò°ø±â.
  • minimal angle resolution
    ÃÖ¼Ò°¢ºÐÇØ´É.
  • minimal auditory threshold
    ÃÖ¼Ò°¡Ã»¿ªÄ¡(õÌ á³Ê¦ôéÚÊö·).
  • minimal auditory threshold
    ÃÖ¼Ò°¡Ã»¿ªÄ¡
  • minimal bactericidal concentration (MBC)
    »ì±ÕÃÖ¼Ò³óµµ
  • minimal blood pressure
    ÃÖ¼ÒÇ÷¾Ð.
  • minimal brain dysfunction
    °æ¹Ì³ú±â´ÉÀå¾Ö.
  • minimal brain dysfunction
    ¹Ì¼Ò³ú±â´ÉÀå¾Ö(Ú°á³ÒàѦÒöî¡äô)
  • minimal change disease
    ¹Ì¼Òº¯È­ »ç±¸Ã¼½Å¿°
  • minimal change disease
    ¹Ì¼Ò º´º¯½ÅÁõ(ڰܻ᳠ܨãìñø)
  • minimal current gradient
    ÃÖ¼ÒÀü·ù°æ»ç(¡­ï³êüÌËÞØ).
  • minimal current gradient
    ÃÖ¼ÒÀü·ù±¸¹è(¡­ï³êüÎþÛÕ).
  • minimal daily requirement
    ÃÖ¼Ò¿µ¾çÇʿ䷮(õÌá³ç½å×ù±é©åÖ), ÃÖ¼ÒÀÏÀϿ䱸·® .
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Pseudoglandular period
    °ÅÁþ»ù½Ã±â
    [¿¾ ¿ë¾î] À§¼±±â
  • Alveolar period
    ²Ê¸®½Ã±â
    [¿¾ ¿ë¾î] ÆóÆ÷±â
  • Prenatal period
    ºÐ¸¸Àü±â
    [¿¾ ¿ë¾î] ºÐ¸¸Àü±â
  • Postnatal period
    ºÐ¸¸Èıâ
    [¿¾ ¿ë¾î] ºÐ¸¸Èıâ
  • Canalicular period
    ¼¼°ü½Ã±â
    [¿¾ ¿ë¾î] ¼¼°ü±â
  • Period of mature neural groove and immature somite
    ½Å°æ°í¶û¼º¼÷ ¹× ¸öºÐÀý¹Ì¼º¼÷±â
    [¿¾ ¿ë¾î] ½Å°æ±¸Çü¼ºÈÄ±â ¹× Ã¼ÀýÇü¼ºÀü±â
  • Initial period of neural groove
    ½Å°æ°í¶ûÃʱâ
    [¿¾ ¿ë¾î] ½Å°æ±¸Çü¼ºÀü±â
  • Period of neural tube
    ½Å°æ°ü±â
    [¿¾ ¿ë¾î] ½Å°æ°ü±â
  • Neonatal period
    ½Å»ý¾Æ±â
    [¿¾ ¿ë¾î] ½Å»ý¾Æ±â
  • Intermitotic period [Interphase]
    À¯»çºÐ¿­»çÀ̱â
    [¿¾ ¿ë¾î] °£±â
  • Mesoderm of the period of branchiogenesis
    ÀεαÁÀ̹߻ý±âÁ߹迱
    [¿¾ ¿ë¾î] ÀεαÃ[»õ±Ã]¹ß»ý±âÁ߹迱
  • Final period of branchial arch
    ÀεαÁÀÌÁ¾±â
    [¿¾ ¿ë¾î] »õ±ÃÁ¾±â
  • Initial period of pharyngeal arch
    ÀεαÁÀÌÃʱâ
    [¿¾ ¿ë¾î] ÀεαÃÀü±â(»õ±ÃÀü±â)
  • Gestational period
    Àӽűâ
    [¿¾ ¿ë¾î] Àӽűâ
  • Period of labial fissure
    ÀÔ¼úÆ´»õ±â
    [¿¾ ¿ë¾î] ±¸¼ø¿­±â
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • extrinsic incubation period
    ¸ð±â³»Àẹ±â
  • incubation period
    Àẹ±â
  • latent period
    Àẹ±â
  • prepatent period
    ÃæÃ¼Àẹ±â
  • residual period
    ÀÜ·ù±â°£
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal medium
    ÃÖ¼Ò¹èÁö(õÌá³ÛÆò¢)
  • minimal stable length
    ÃÖ¼Ò¾ÈÁ¤(õÌá³äÌïÒ) ±æÀÌ
  • conversion period
    Àüȯ±â°£(ï®üµÑ¢Êà)
  • half-period
    ¹Ý±â°£(ÚâÑ¢Êà)
  • incubation period
    Àẹ±â(íÖÜÑÑ¢)
  • induction period
    À¯µµ±â°£(ë¯ÓôÑ¢Êà)
  • lag period
    Áöü½Ã°£(òÀôòãÁÊà)
  • latent period
    Àẹ±â(íÖÜÑÑ¢)
  • long period intersperion
    Àå±â »êÀç(íþѢߤî¤)
  • short period intespersion
    ´Ü±â°£ »êÀç(Ó­Ñ¢Êàߤî¤)
  • unit evolutionary period
    ´ÜÀ§(Ó¤êÈ) ÁøÈ­±â°£ (òäûùÑ¢Êà)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal
    ÃÖ¼ÒÀÇ
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • minimal enhancement
    ¹Ì¹ÌÇÑÁ¶¿µÁõ°­, °æµµÀÇÁ¶¿µÁõ°­
  • incubation period
    Àẹ±â, º¸¿Â±â°£, ¹è¾ç±â°£
  • latent period
    Àẹ±â, Àẹ½Ã, ÀáÀڱؽÃ, Àẹ±â°£
  • period
    ÁÖ±â, ±â, ±â°£, ½Ã´ë
  • pulse repetition period
    ÆÞ½º¹Ýº¹ÁÖ±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HFRS Hemorrhagic Fever with Renal Syndrome [HP 849-50]
  = Korean Hemorrhagic Fever
&nbs...
MRD maximum rate of depolarization; measles-rindenpest-distemper [virus group]; medical records departme...
IP icterus praecox; imaging plate; immune precipitate; immunoblastic plasma; immunoperoxidase technique...
MBD Marchiafava-Bignami disease; Mental Deterioration Battery; methylene blue dye; minimal brain damage;...
MCD magnetic circular dichroism; mast-cell degranulation; mean cell diameter; mean of consecutive differ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EMEM Eagle's Minimal Essential Medium
MAS Minimal Access Surgery
MAC Minimal Alveolar Concentration
MBC Minimal Bactericidal Concentration
MBD Minimal Brain Dysfunction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Eagle`s minimal essential medium
    ÀÌ±Û ¹èÁö
    ¼¼Æ÷ ¹è¾ç¾×ÀÇ ÀÏÁ¾. 3Á¾·ùÀÇ ¾Æ¹Ì³ë»ê°ú 8Á¾·ùÀÇ ºñŸ¹ÎÀ» ÇÔÀ¯Çϰí ÀÖÀ¸¸ç º¸Åë Ç÷û 5% ÀÌÇÏ¿¡¼­ À¯Áö ¹èÁö·Î¼­ »ç¿ëµÇ°í 10-20%ÀÇ Ç÷û ÷°¡·Î ¸¹Àº ¼¼Æ÷´Â ±ØÈ÷ ¾çÈ£ÇÑ ¹ßÀ°À» ³ªÅ¸³½´Ù.
  • minimal
    ÃÖ¼ÒÀÇ
    °¡Àå °¡´É¼ºÀÌ ÀûÀº.
  • minimal dose
    ÃÖ¼Ò·®
  • minimal enhancement
    ¹Ì¹ÌÇÑ Á¶¿µ Áõ°­, °æµµÀÇ Á¶¿µ Áõ°­
  • minimal identifiable odor
    ÃÖ¼Ò ºÐÇØ Ãë°¢
  • minimal requirement
    ÃÖ¼Ò ±Ô°Ý
  • minimal temperature
    ÃÖÀú ¿Âµµ
  • alveolar period
    ²Ê¸® ½Ã±â
  • childbearing period
    Àӽа¡´É ±â°£
  • competent period
    ¼ö¿ë±â
  • critical period
    ƯÁ¤Àû ½Ã±â
  • demi-period
    ¹Ý°¨±â
    ¹æ»ç¼º ¹°ÁúÀÇ ¹æ»ç·ÂÀÌ ÃÖÃÊÀÇ ¹æ»ç·ÂÀÇ ¹ÝÀ¸·Î ÁÙ¾îµå´Â ±â°£.
  • embryonic period
    ¹èÀÚ±â, ¹è¾Æ±â
  • eruption period of deciduous teeth
    À¯Ä¡ ¸ÍÃ⠽ñâ
  • formal operational period
    Çü½ÄÀû Á¶ÀÛ±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
volition Voluntary activity without external compulsion.
(12 Dec 1998)
minimal Smallest or least, the smallest possible.
Origin: L. Minimus = least
(18 Nov 1997)
minimal air The volume of gas that remains in the lungs and cannot be expelled after they have been removed from the body, or after the chest has been opened.
(05 Mar 2000)
minimal alveolar concentration The end-alveolar concentration of an inhalation anaesthetic which prevents somatic response to a painful stimulus in 50% of individuals; an index of relative potency of inhalation anaesthetics.
Synonym: minimal anaesthetic concentration.
(05 Mar 2000)
minimal amplitude nystagmus Nystagmus of so small an amplitude that it is not detected by the usual clinical tests.
Synonym: minimal amplitude nystagmus.
Origin: micro-+ G. Nystagmos, a nodding
(05 Mar 2000)
minimal anaesthetic concentration The end-alveolar concentration of an inhalation anaesthetic which prevents somatic response to a painful stimulus in 50% of individuals; an index of relative potency of inhalation anaesthetics.
Synonym: minimal anaesthetic concentration.
(05 Mar 2000)
minimal brain dysfunction An inability to control behaviour due to difficulty in processing neural stimuli.
(12 Dec 1998)
minimal-change disease <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure.
This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness.
It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown.
Risk factors include a history for a immune disorder, recent immunisation or a bee sting.
Diagnosis is made by renal biopsy.
Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented.
Synonym: lipoid nephrosis
(27 Sep 1997)
minimal-change nephrotic syndrome <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure.
This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness.
It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown.
Risk factors include a history for a immune disorder, recent immunisation or a bee sting.
Diagnosis is made by renal biopsy.
Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented.
Synonym: lipoid nephrosis
(27 Sep 1997)
minimal deviation melanoma <dermatology, tumour> A malignant melanoma showing less cytologic atypia than is usual in melanoma cells showing asymmetric expansile invasion of the dermis.
(05 Mar 2000)
minimal dose <pharmacology> The smallest amount of a drug or physical procedure that will produce a desired physiologic effect in an adult.
(05 Mar 2000)
minimal infecting dose <microbiology> The smallest quantity of infectious material regularly producing infection; usually expressed as I.D.50, the quantity causing infection in 50% of a suitable series of animals or cells (cell cultures).
(05 Mar 2000)
minimal inhibitory concentration <microbiology, pharmacology> The lowest concentration of antibiotic sufficient to inhibit bacterial growth when tested in vitro.
(05 Mar 2000)
minimal lethal dose <pharmacology> The minimal dose of a toxic substance or infectious agent that is lethal, as assayed in various experimental animals (e.g., the least amount of diphtheria toxin that, on an average, kills a 250-g guinea pig within 96 hours after subcutaneous inoculation).
When followed by a subscript (generally "MLD50"), denotes the minimal dose that is lethal to a certain percentage (e.g., 50%) of animals so assayed, LD05.
See: lethal dose.
(05 Mar 2000)
minimal medium <cell culture> The simplest tissue culture medium that will support the proliferation of normal cells.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • volition
    ÀÇ¿å; °á´Ü; ÀÇÁö
  • volition
    ÀÇÁöÀÇ ÀÛ¿ë;ÀÇ¿å;ÀÇÁö·Â;ÀÇÁö;°áÀÇ;¼±ÅÃ
  • minimal
    ±Ø¼ÒÀÇ; ÃÖÀúÀÇ
  • minimal
    ÃÖ¼ÒÇâ(¼ö)ÀÇ;±Ø¼ÒÀÇ
  • minimal art
    ¹Ì´Ï¸Ö ¾ÆÆ®;ÃÖ¼ÒÇÑÀÇ Á¶Çü ¼ö´ÜÀ¸·Î Á¦ÀÛµÈ ±×¸²;Á¶°¢
  • minimal brain dysfunction
    ¹Ì¼Ò ³ú±â´É Àå¾Ö (¾Æµ¿ÀÇ ÇнÀ Àå¾ÖÀÇ Çϳª)
  • minimal pair
    ÃÖ¼Ò ´ë¾î(bet¿Í bed ó·³ °°Àº À§Ä¡ÀÇ ÇÑ °¡Áö ¼Ò¸®¸¸ ´Ù¸¥ ÇÑ ½ÖÀÇ ³¹¸»)
  • period
    ±â°£,½Ã´ë,Á¾ÁöºÎ
  • cooling-off period
    ³Ã°¢ ±â°£
  • glacial epoch(period)
    ºùÇϱâ(½Ã´ë)
  • glacial period
    ºùÇÏ ½Ã´ë
  • grace period
    À¯¿¹±â°£
  • halflife period
    (¹æ»ç¼º ¿ø¼Ò µîÀÇ)¹Ý°¨±â
  • honeymoon period
    (¹Ì)(´ëÅë·É ÃëÀÓÈÄ ¾à 3°³¿ù°£ÀÇ È£ÀǸ¦ ¹Þ´Â)¹Ð¿ù ±â°£
  • monthly period
    ¿ù°æ(±â°£)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á